Candidate gene case-control studies

被引:19
作者
Daly, AK [1 ]
机构
[1] Newcastle Univ, Pharmacogenet Grp, Sch Clin & Lab Sci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
cancer; candidate gene; DNA repair; single nucleotide polymorphism; xenobiotic metabolism;
D O I
10.1517/phgs.4.2.127.22629
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two main approaches to the identification of genes are involved in polygenic diseases. Use of family studies has generally been the preferred approach up until recently, but this is only feasible if the genetic component of the disease is relatively strong and DNA samples are available from other family members. Population case-control studies are useful both as an alternative and an adjunct to family studies. These can involve either whole genome scanning or candidate gene approaches. While whole genome scanning is likely to be widely used in the future once more information on genome-wide single nucleotide polymorphism distributions is available, at present, candidate gene studies are more feasible. When performing candidate gene case-control studies factors such as study design, methods for recruitment of case and controls, selection of candidate genes, functional significance of polymorphisms chosen for study and statistical analysis require close attention to ensure that only genuine associations are detected. Some examples of the successful use of candidate gene case-control studies are discussed and, to illustrate some potential problems in the design and interpretation of association studies, some specific examples of association studies on cancer are considered.
引用
收藏
页码:127 / 139
页数:13
相关论文
共 110 条
[71]   Searching for genetic determinants in the new millennium [J].
Risch, NJ .
NATURE, 2000, 405 (6788) :847-856
[72]   Pharmacogenetics and the practice of medicine [J].
Roses, AD .
NATURE, 2000, 405 (6788) :857-865
[73]   Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease [J].
Rostami-Hodjegan, A ;
Lennard, MS ;
Woods, HE ;
Tucker, GT .
PHARMACOGENETICS, 1998, 8 (03) :227-238
[74]   IDENTIFICATION OF AN NAD(P)H-QUINONE OXIDOREDUCTASE POLYMORPHISM AND ITS ASSOCIATION WITH LUNG-CANCER AND SMOKING [J].
ROSVOLD, EA ;
MCGLYNN, KA ;
LUSTBADER, ED ;
BUETOW, KH .
PHARMACOGENETICS, 1995, 5 (04) :199-206
[75]   An improved assay shows no association between the CYP2A6 gene and cigarette smoking behavior [J].
Sabol, SZ ;
Hamer, DH .
BEHAVIOR GENETICS, 1999, 29 (04) :257-261
[76]   A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer [J].
Sachse, C ;
Smith, G ;
Wilkie, MJV ;
Barrett, JH ;
Waxman, R ;
Sullivan, F ;
Forman, D ;
Bishop, DT ;
Wolf, CR .
CARCINOGENESIS, 2002, 23 (11) :1839-1849
[77]   ASSOCIATION OF APOLIPOPROTEIN-E ALLELE EPSILON-4 WITH LATE-ONSET FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE [J].
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, D ;
GEORGEHYSLOP, PHS ;
PERICAKVANCE, MA ;
JOO, SH ;
ROSI, BL ;
GUSELLA, JF ;
CRAPPERMACLACHLAN, DR ;
ALBERTS, MJ ;
HULETTE, C ;
CRAIN, B ;
GOLDGABER, D ;
ROSES, AD .
NEUROLOGY, 1993, 43 (08) :1467-1472
[78]   Use of parents, sibs and unrelated controls for detection of associations between genetic markers and disease [J].
Schaid, DJ ;
Rowland, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (05) :1492-1506
[79]   Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants [J].
Schwarz, D ;
Kisselev, P ;
Cascorbi, I ;
Schunck, WH ;
Roots, I .
CARCINOGENESIS, 2001, 22 (03) :453-459
[80]   A GLUTATHIONE TRANSFERASE IN HUMAN-LEUKOCYTES AS A MARKER FOR THE SUSCEPTIBILITY TO LUNG-CANCER [J].
SEIDEGARD, J ;
PERO, RW ;
MILLER, DG ;
BEATTIE, EJ .
CARCINOGENESIS, 1986, 7 (05) :751-753